Shailza Verma1, Rahul Saxena2, Merajul Haque Siddiqui3, Karunathy Santha4, Subramaniam Sethupathy5. 1. Assistant Professor, Department of Biochemistry, School of Medical Sciences and Research, Sharda University, Greater Noida, Uttar Pradesh, India. 2. Assistant Professor, Department of Biochemistry, School of Allied Health Sciences, Sharda University, Greater Noida, Uttar Pradesh, India. 3. Postgraduate Student, Final year, Department of Biochemistry, School of Medical Sciences and Research, Sharda University, Greater Noida, Uttar Pradesh, India. 4. Professor, Department of Biochemistry, Rajah Muthiah Medical College, Annamalai University, Annamalai Nagar, Tamil Nadu, India. 5. Professor and Head, Department of Biochemistry, Rajah Muthiah Medical College, Annamalai University, Annamalai Nagar, Tamil Nadu, India.
Abstract
INTRODUCTION: Oral Squamous Cell Carcinoma (OSCC) affects global health with increasing incidence and mortality rate. It may involve exposure to carcinogens from tobacco smoking or chewing. Alteration in expression of gene encoding the enzymes concerned with carcinogen biotransformation along with oxidative stress may increase or decrease the risk of cancer. AIM: To evaluate the expression of CYP1B1 gene in OSCC patients along with its relation with oxidative stress and phase 2 detoxification enzyme status. MATERIALS AND METHODS: In the present study, CYP1B1 genotypic analysis was carried out along with estimation of serum Total Antioxidant Activity (TAA), erythrocyte Malondialdehyde (MDA) levels and serum Glutathione-S-Transferase (GST) activity in 20 OSCC patients and statistically compared with that of age matched 20 healthy subjects, served as control by using student's t-test. RESULTS: It was observed that 85% of histopathologically diagnosed OSCC patients had CYP1B1 expression with significantly elevated levels of MDA (p<0.001). In addition, plasma total antioxidant status and serum GST levels were decreased significantly (p<0.05) in OSCC patients as compared to the healthy controls to overcome the burden of oxidative stress. CONCLUSION: On the basis of the present study, we conclude that the expression of CYP1B1 is an important determinant of carcinogenesis and significantly associated with oxidative stress characterized by decreased serum GST and total antioxidant levels in OSCC patients.
INTRODUCTION:Oral Squamous Cell Carcinoma (OSCC) affects global health with increasing incidence and mortality rate. It may involve exposure to carcinogens from tobacco smoking or chewing. Alteration in expression of gene encoding the enzymes concerned with carcinogen biotransformation along with oxidative stress may increase or decrease the risk of cancer. AIM: To evaluate the expression of CYP1B1 gene in OSCC patients along with its relation with oxidative stress and phase 2 detoxification enzyme status. MATERIALS AND METHODS: In the present study, CYP1B1 genotypic analysis was carried out along with estimation of serum Total Antioxidant Activity (TAA), erythrocyte Malondialdehyde (MDA) levels and serum Glutathione-S-Transferase (GST) activity in 20 OSCC patients and statistically compared with that of age matched 20 healthy subjects, served as control by using student's t-test. RESULTS: It was observed that 85% of histopathologically diagnosed OSCC patients had CYP1B1 expression with significantly elevated levels of MDA (p<0.001). In addition, plasma total antioxidant status and serum GST levels were decreased significantly (p<0.05) in OSCC patients as compared to the healthy controls to overcome the burden of oxidative stress. CONCLUSION: On the basis of the present study, we conclude that the expression of CYP1B1 is an important determinant of carcinogenesis and significantly associated with oxidative stress characterized by decreased serum GST and total antioxidant levels in OSCC patients.
Entities:
Keywords:
Cytochrome P450; Free radicals; Glutathione S transferase; Oral cancer; Total antioxidant status
Authors: L L Song; J W Kosmeder; S K Lee; C Gerhäuser; D Lantvit; R C Moon; R M Moriarty; J M Pezzuto Journal: Cancer Res Date: 1999-02-01 Impact factor: 12.701
Authors: Angela C Chi; Kathryn Appleton; Joel B Henriod; Joe W Krayer; Nicole M Marlow; Dipankar Bandyopadhyay; Ryan C Sigmon; David T Kurtz Journal: Oral Oncol Date: 2009-07-02 Impact factor: 5.337
Authors: Jeanie K Meckes; Patrick H Lim; Stephanie L Wert; Wendy Luo; Stephanie A Gacek; Dana Platt; Ryan Jankord; Kathrin Saar; Eva E Redei Journal: PLoS One Date: 2018-03-12 Impact factor: 3.240